Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Journal of Psychoactive Drugs|January 30, 1999
Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactionsJ C Callaway, C S GrobJournal of Developmental and Behavioral Pediatrics : JDBP|August 1, 1986
Suspected adverse methylphenidate-imipramine interactions in childrenC S Grob, J T CoyleBehavioural Brain Research|January 1, 1996
Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observationsC S Grob, R E Poland, L Chang, et al.Journal of Magnetic Resonance Imaging : JMRI|October 3, 1999
Cerebral (1)H MRS alterations in recreational 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy") usersL Chang, T Ernst, C S Grob, et al.The Journal of Nervous and Mental Disease|June 1, 1992
Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine useM B Liester, C S Grob, G L Bravo, et al.Psychopharmacology|November 1, 1994
Platelet serotonin uptake sites increased in drinkers of ayahuascaJ C Callaway, M M Airaksinen, D J McKenna, et al.Psychiatry Research|March 10, 2000
Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI studyL Chang, C S Grob, T Ernst, et al.Journal of Analytical Toxicology|October 1, 1996
Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuascaJ C Callaway, L P Raymon, W L Hearn, et al.Psychopharmacology|June 1, 1997
Abnormal ACTH and prolactin responses to fenfluramine in rats exposed to single and multiple doses of MDMAR E Poland, P Lutchmansingh, J T McCracken, et al.Pageof 2